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Abstract
The amyloidotic form of bovine spongiform encephalopathy (BSE) termed BASE is caused by a prion strain whose
biological properties differ from those of typical BSE, resulting in a clinically and pathologically distinct phenotype.
Whether peripheral tissues of BASE-affected cattle contain infectivity is unknown. This is a critical issue since the BASE
prion is readily transmissible to a variety of hosts including primates, suggesting that humans may be susceptible. We
carried out bioassays in transgenic mice overexpressing bovine PrP (Tgbov XV) and found infectivity in a variety of skeletal
muscles from cattle with natural and experimental BASE. Noteworthy, all BASE muscles used for inoculation transmitted
disease, although the attack rate differed between experimental and natural cases (,70% versus ,10%, respectively). This
difference was likely related to different prion titers, possibly due to different stages of disease in the two conditions, i.e.
terminal stage in experimental BASE and pre-symptomatic stage in natural BASE. The neuropathological phenotype and
PrP
res type were consistent in all affected mice and matched those of Tgbov XV mice infected with brain homogenate
from natural BASE. The immunohistochemical analysis of skeletal muscles from cattle with natural and experimental BASE
showed the presence of abnormal prion protein deposits within muscle fibers. Conversely, Tgbov XV mice challenged
with lymphoid tissue and kidney from natural and experimental BASE did not develop disease. The novel information on
the neuromuscular tropism of the BASE strain, efficiently overcoming species barriers, underlines the relevance of
maintaining an active surveillance.
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Introduction
In 2004 an atypical form of bovine spongiform encephalopathy
(BSE) termed BASE or BSE-L was identified in Italy through
active surveillance [1] and subsequently recognized in different
European countries, North America, Canada and Japan [1–6].
BASE affects relatively old cattle (all cases were older than 9 years)
and differs from BSE with regard to the neuropathological
phenotype, the biochemical profile of the disease-associated prion
protein (PrP
Sc) and the biological properties of the agent strain
[1,3,7]. The neuropathological hallmark of BASE is the presence
of PrP amyloid plaques and the preferential involvement of
olfactory areas, hippocampus and thalamus with a relatively low
involvement of the brainstem, as opposed to classical BSE. The
molecular signature of BASE is a PrP
Sc type distinguished by a
protease-resistant core (PrP
res) of lower molecular mass than BSE-
PrP
Sc, with predominance of the monoglycosylated protein band
by western immunoblot.
Intra-species transmission revealed that the clinical picture of
BASE differs substantially from that of BSE, being characterized
by mental dullness and amyotrophy rather than hyper-reactivity
and aggressiveness [8,9]. As a consequence, the recognition of
BASE in vivo can be difficult and may represent a major challenge
for passive surveillance. Transmission studies to transgenic mice
overexpressing bovine PrP (Tgbov mice) showed that the BASE
strain is more aggressive than the BSE strain [10]. Furthermore,
Tg mice overexpressing human PrP as well as non-human
primates are more susceptible to infection with BASE than with
BSE [11–14]. Overall these data raise concern about the potential
risk of transmission of BASE to humans and it is urgent to
determine the presence and distribution of infectivity in peripheral
tissues of BASE-affected cattle. To investigate this issue, we
inoculated Tgbov mice with different peripheral tissues from
experimentally and naturally BASE-affected cattle and found that
various skeletal muscles contained infectivity and PrP-immunore-
active deposits within individual fibers.
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Skeletal muscle of cattle with experimental BASE
contains infectivity
Transgenic mice overexpressing bovine PrP on a mouse PrP
knock-out background (Tgbov XV line) [15] were injected both
intracerebrally (i.c.) and intraperitoneally (i.p.) with 10% homog-
enate of longissimus dorsi muscle obtained from an Alpine brown
cow intracerebrally infected with BASE and culled at terminal
stage of disease (#995) [8] (Table 1). As positive control, groups of
mice were inoculated with brain homogenates from the same
experimentally BASE-infected cattle and from a natural BASE
identified by active surveillance (#12966/07). No PrP
res was
detected in muscle homogenate used for inoculation by immuno-
blot analysis without or with PrP
res enrichment with phospho-
tungstic acid (PTA) precipitation [16].
All mice infected with experimental (5/5) or natural (5/5) BASE
brain homogenate developed the disease with comparable
incubation period (mean 6 standard error of the mean [s.e.m.]:
186610 and 17866 days) and survival time (mean 6 s.e.m.:
21569 and 21168 days). Noteworthy, five out of seven mice
challenged with the longissimus dorsi muscle developed a progressive
neurological disease with incubation periods ranging from 347 to
430 days (mean 6 s.e.m.: 380611 days) and survival times ranging
from 364 to 430 days (mean 6 s.e.m.: 410612 days). As observed
in mice infected with BASE brain tissue, clinical signs of disease
consisted of lethargy, hindlimb weakness and amyotrophy, and
weight loss.
The neuropathological profile, immunohistochemical pattern of
PrP
res deposition and PrP
res type were identical in Tgbov XV mice
challenged with BASE muscle or BASE brain, and differed from
that of mice injected with the BSE strain. In fact, the
histopathological lesion profile (i.e. extent of vacuolar degenera-
tion in standard brain regions) was marked by major involvement
of somatosensory cortex and superior colliculus as opposed to a
substantial sparing of these regions in BSE-infected mice
(Figure 1A). Immunohistochemistry showed diffuse PrP
res deposi-
tion in the cerebral cortex, particularly in the somatosensory
region, basal ganglia, thalamus, hypothalamus, brainstem and
cerebellum, accompanied by some focal PrP deposits, whereas
amyloid plaques were absent as revealed by specific staining for
amyloid (Figure 1C, D, E, F, G, H). The PrP
res type was
characterized by prevalence of the monoglycosylated dominant
profile and faster electrophoretic migration compared to BSE-
infected mice (Figure 1B).
Skeletal muscle of cattle with natural BASE contains
infectivity
As a subsequent step in our study, we inoculated Tgbov XV
mice both i.c. and i.p. with 10% homogenate of two different
muscles (intercostalis and gluteus muscles) from a 14-year-old
asymptomatic Piemontese cow with natural BASE (#12966/07)
(Table 1). Transmission to mice was observed from both muscles,
although the attack rate was less efficient than that of mice injected
with the experimental BASE muscle. One out of seven mice
challenged with intercostal muscle and one out of nine mice
challenged with gluteal muscle developed clinical signs of disease
with incubation time of 370 and 498 days, and survival time of 396
and 541 days, respectively. The lesion profile, the pattern of PrP
res
deposition, the brain regional distribution and the biochemical
type of PrP
res were identical to those observed in mice inoculated
with muscle from cattle with experimental BASE (Figure 1A and
Figure 1I, J, K, L, M).
Skeletal muscle of BASE-affected cattle contains
abnormal PrP deposits
Immunohistochemical analysis showed the presence of PrP
deposits in 2 out of 6 muscles (i.e., M. longissimus dorsi and M.
pectoralis profundus) obtained from the experimental BASE used for
transmission studies (#995). Furthermore, immunoreactivity was
detected in 4 out of 16 muscles (i.e., M. trapezius, M. biceps femoris,
M. semitendinosus and M. peroneus) from a distinct case of natural
BASE (#126752/09) (Tables 2 and 3). In both cases, PrP
deposition was observed inside the cytoplasm of isolated fibers with
a scattered distribution, mainly as small amorphous aggregates
and, less frequently, in the form of granular deposits (Figure 2).
PrP immunoreactivity was abolished by preabsorption of the
antibody with a peptide comprising the antibody epitope. Muscle
samples from negative control cattle consistently gave negative
results. The PrP immunoreactive deposits did not show the
staining properties of amyloid as revealed by absence of staining
with the amyloid-binding dye X-34. Neither muscle atrophy nor
Table 1. Transmission of BASE to Tgbov XV mice following inoculation of different tissues.
Tissue sample N6 diseased/N6 inoculated Incubation time (days) Survival time (days)
EXPERIMENTAL BASE (#995)
Brain 5/5 186610 21569
Longissimus dorsi muscle 5/7 380611 410612
Kidney 0/9 / .850
Spleen 0/7 / .850
Lymph node 0/14 / .850
NATURAL BASE (#12966/07)
Brain 5/5 178662 1 1 68
Gluteus muscle 1/7 370 396
Intercostalis muscle 1/9 498 541
Kidney 0/8 / .850
Spleen 0/8 / .850
Incubation and survival times are expressed in days as mean 6 s.e.m.
doi:10.1371/journal.pone.0031449.t001
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sections from natural BASE stained with hematoxylin-eosin, while
muscles from experimentally infected cattle showed a remarkable
amyotrophy [8]. WB analysis of samples of skeletal muscles used
for immunohistochemistry did not reveal presence of PrP
res either
without or with PTA precipitation.
Lymphoid tissue and kidney of BASE-affected cattle do
not contain infectivity
Finally, we investigated the presence of infectivity in the
lymphoreticular and urinary system of experimentally and
naturally BASE-affected cattle by inoculation of groups of Tgbov
XV mice with 10% homogenates of spleen, cervical lymph node
and kidney (Table 1). None of the mice developed clinical signs of
neurological dysfunction and were culled close to their predicted
life span (850 days after challenge). Post-mortem examination did
not reveal any neuropathological change or PrP
res accumulation
by immunohistochemistry or Western blot analysis following PTA
precipitation.
Discussion
This is the first report on the occurrence and distribution of
infectivity in peripheral tissues of BASE-affected cattle. We found
that different skeletal muscles (i.e., M. longissimus dorsi, M. intercostalis
and M. gluteus) from experimental and natural BASE carried
infectivity, whereas spleen, cervical lymph node and kidney did
not, as highly susceptible Tgbov XV mice did not develop disease
up to 850 days after challenge. Noteworthy, all BASE muscles
used for inoculation transmitted disease, although the attack rate
differed between experimental and natural cases. This difference is
likely related to different prion titers in the two conditions, possibly
due to different stages of disease. In fact, the experimentally
Figure 1. Transmission of BASE to Tgbov XV mice following
inoculation of muscles from experimentally and naturally
affected cattle. (A) Lesion profiles of mice infected with brain tissue
from natural BASE (blue line) and BSE (green line), longissimus dorsi
muscle from experimental BASE (red line) and intercostalis (bordeaux
line) and gluteus (yellow line) muscles from natural BASE. Vacuolation
was scored on a scale of 0–5 in the following brain areas: 1, dorsal
medulla; 2, cerebellar cortex; 3, superior colliculus; 4, hypothalamus; 5,
thalamus; 6, hippocampus; 7, septum; 8, retrosplenial and adjacent
motor cortex; and 9, cingulated and adjacent motor cortex. Data are
mean 6 s.e.m. (B) Western blot analysis of proteinase K-digested brain
samples of mice infected with brain homogenates from cattle with
natural BASE (#12966/07) and BSE, longissimus dorsi muscle from cattle
with experimental BASE (#995) and two different muscles from natural
BASE (#12699/07). (C–M) Neuropathological changes of mice infected
with brain (C–E) and muscle from cattle with experimental BASE (F–H),
and muscle from cattle with natural BASE (I–M). Micrographs were
obtained from corresponding areas of the thalamic region stained with
haematoxylin-eosin (C,F,I) or labeled with the anti-PrP antibody 6H4.
The severity of vacuolation and the type of PrP deposition,
characterized by diffuse immunostaining of the neuropil with focal
enhancement, is similar in all the samples analyzed. Scale bar=100 mm.
doi:10.1371/journal.pone.0031449.g001
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signs were severe [8], while the cattle with natural BASE was
identified through active surveillance at a pre-symptomatic stage.
Infectivity in skeletal muscles has been detected in various
natural and experimental prion diseases, including sheep affected
by classical and Nor/98 atypical scrapie [17], deer with chronic
wasting disease [18] and rodent models of scrapie [19]. A large
pathogenesis study on BSE-infected cattle in the UK failed to
detect infectivity in muscle tissue at any time during the course of
the disease by inoculation of inbred mice [20]. However, in a
subsequent study with Tgbov XV mice, M. semitendinosus from a
field case of clinically symptomatic BSE transmitted disease to one
out of ten inoculated rodents. This low amount of infectivity was
tentatively related to the terminal nerve fibres [21].
A major clinical feature of cattle experimentally infected with
BASE is amyotrophy, as a result of motor neuron disease [8].
Although we were unable to detect PrP
Sc in the peripheral nerves
of infected cattle and follow the kinetics of PrP spreading through
the neural pathway, a study of intra-species transmission of a
Japanese case of BASE showed that PrP
res was first detectable by
immunoblot in the nerve roots and subsequently in the peripheral
nerves [22]. PrP
res deposition in skeletal muscles has been found in
a variety of prion diseases, including experimental scrapie in
hamsters [23], natural scrapie in sheep [24], and mouse and
primate models of BSE and CJD [25–27]. These reports agree that
PrP
res in muscle tissue is associated with terminal nerve endings.
In our study, immunohistochemistry showed the presence of
amorphous or granular, small PrP deposits in different skeletal
muscles from both experimental and natural BASE-affected cattle.
PrP aggregates were found in isolated muscle fibers with a scattered
distribution which was at variance with the topology of PrP
res
reported in the previous studies [23,24,26,27]. Noteworthy, identical
results were obtained using two different fixatives and immunostain-
ing protocols. Since PrP
C is expressed in bovine muscles and skeletal
muscles are intrinsically capable of propagating prions [19,28], we
argue that PrP
Sc deposition in BASE muscles might be the result of a
primary PrP replication through a neural-independent pathway. This
possibility has been previously considered in a patient affected by
sporadic CJD and inclusion body myositis where PrP
C to PrP
Sc
conversion occurred in skeletal muscle [29].
The limited number and irregular distribution of PrP positive
fibers within a muscle sample accounts for the absence of a
detectable PrP
res signal on Western blot. The inhomogeneous
distribution of PrP
res and infectivity among different muscles of the
same animal and within the same muscle has been previously
observed in mice and in primates infected with different prion
strains. These findings have been tentatively related to biochemical
differences in skeletal muscles of different body regions and/or
number of nerve endings [19,25,26].
In the present study, Tgbov XV mice challenged with BASE
muscles reproduced the monoglycosylated-dominant PrP
res type of
BASE as well as a histopathological lesion profile and pattern of
PrP
res deposition that matched those observed in mice challenged
with BASE brain. These findings indicate that, in Tgbov XV mice,
muscle and brain tissues maintain the same biological properties of
the BASE strain.
Although serial transmission studies in Tgbov XV mice showed
that the BASE prion is capable to replicate in the spleen
converting, in part, into a BSE-like strain (personal observation),
Table 3. PrP immunohistochemistry of muscle samples from
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Figure 2. PrP deposition in the muscles of natural BASE cattle.
(A–C) PrP deposits in peroneus muscle from a cattle with natural BASE
(#126752/09). The PrP-imunoreactive material was found in isolated
muscle fibers with a scattered distribution (A,C) and was localized inside
the cytoplasm in the form of small amorphous aggregates or granular
deposits (B). Scale bar=100 mm for figure A and C; =20 mm for figure B.
doi:10.1371/journal.pone.0031449.g002
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with experimental and natural BASE. This observation opposes
the possibility that the BASE agent might re-circulate, potentially
as BSE-like strain, in different hosts. Kidney is an edible organ and
infectivity found in urine is kidney-associated [30]. Lack of
transmission from kidney of natural and experimental BASE is an
important issue, since infectivity in kidney has been demonstrated
by bioassay in human prion diseases [31], and PrP
Sc has been
observed in kidney of scrapie infected sheep and CWD affected
deer [32–34].
The present data offer novel information on the tropism of the
BASE agent and highlight relevant public health issues. While the
transmission barrier for classical BSE is high in most species,
BASE prions are readily transmissible to a variety of mammals
including non-human primates [11–13,35]. Accordingly, the
possibility of spreading of BASE prions through skeletal muscle




This study was carried out in strict accordance with guidelines
of the Italian Ministry of Health. The use and care of mice
followed the EU directive 86/609/EEC (Council Directive of 24
November 1986 on the approximation of laws, regulations and
administrative provisions of the Member States regarding the
protection of animals used for experimental and other scientific
purposes) and the Italian Legislative Decree 116/92 (Gazzetta
Ufficiale della Repubblica Italiana 10, 18 February 1992). The
study, including its Ethics aspects, was approved by the Italian
Ministry of Health (Permit Number: NP-01-06). All surgery was
performed under sevoflorane anesthesia, and all efforts were made
to minimize suffering.
Animal tissues sampling
Different tissues were collected from an Alpine brown cow
(#995) that was experimentally infected by intracerebral inocu-
lation of 10% brain homogenate from a cow with natural BASE
and culled at the terminal stage of disease [8]. In addition, a
variety of tissues was obtained from the third (#12966/07) and
fourth (#126752/09) cases of natural BASE identified in Italy in
2007 and 2009 (Tables 1, 2, 3). These were an asymptomatic 14-
year-old Piemontese cow and an asymptomatic 13-year-old
Holstein-Friesian cow identified through active surveillance using
a rapid screening test (PRIONICS-CHECK PrioSTRIP, Prionics,
Zurich, Switzerland); in both cases the diagnosis was confirmed by
histology, PrP immunohistochemistry and Western blot analysis.
Each tissue sample was cut in two halves, one of which was fixed
either in Carnoy solution or 10% formaldehyde whereas the other
one was frozen at 280uC. Samples of the same tissues were
collected from three regularly slaughtered, normal cattle and used
as negative controls.
Transmission studies
Groups of Tgbov XV mice [15] were injected by a combination
of i.c. (20 ml) and i.p. (100 ml) routes with 10% homogenate of
occipital cortex and extracts prepared from different peripheral
tissues from experimental BASE (#995) including spleen, kidney,
cervical lymph node and longissimus dorsi muscle, and from the
natural BASE (#12966/07) including spleen, kidney, and
intercostalis and gluteus muscles. Five hundred milligrams of each
sample were homogenized manually using a teflon-on-glass
(Potter-Elvehjem) homogenizer (VWR International, Radnor,
Pennsylvania, USA); the resulted suspension was clarified with
low-speed centrifugation (1,0006g) for 1 min, using an Eppendorf
5418 centrifuge (Eppendorf s.r.l., Hamburg, Germany), and the
pellet discarded. None of the peripheral tissues used for
inoculation showed PrP
res by Western blot analysis without or
with PTA enrichment.
All inocula were prepared under strict aseptic conditions in a
microbiological containment level 3 laboratory, using disposable
material for each inoculum to avoid cross-contamination. Groups
of mice inoculated with BSE brain and normal cattle brain were
included in the study as controls. Behavioral monitoring was
carried out twice a week for detection of the onset of clinical
symptoms and included spontaneous locomotor activity in the
open field, reactivity to external stimuli and inverted screen test
[36–38]. Clinically affected mice were sacrificed at the terminal
stage of disease while all other mice were monitored for the entire
predicted life span (up to 850 days) and then culled and subjected
to autopsy.
Histopathology and immunohistochemistry
At autopsy, the left lateral two-thirds of each mouse brain was
fixed in Carnoy solution (ethanol:chloroform:acetic acid, 6:3:1)
and serial 5-mm-thick sections from paraffin-embedded blocks
were stained with hematoxylin-eosin (HE) and thioflavine S, or
probed with the anti-PrP monoclonal antibody 6H4 (Prionics AG,
Zu ¨rich, Switzerland, 1:1000) and a polyclonal antibody to glial
fibrillary acidic protein (Dakocytomation, Carpinteria, CA, USA,
1:1000). Lesion profiles were established following the standard
method described previously [39] using nine standard grey matter
areas of the brains. Before PrP immunostaining, the sections were
pretreated with proteinase K (Boehringer Mannheim, Ingelheim
am Rhein, Germany) followed by guanidine isothiocyanate as
reported previously [40]. Immunoreactions were revealed with the
Envision System (Dakocytomation) for the polyclonal antibody or
the Animal Research Kit Peroxidase (Dakocytomation) for the
monoclonal antibody, using 3,39-diaminobenzidine (Dakocytoma-
tion) as a chromogen.
Two different protocols were followed to immunostain the
muscle samples, depending on the type of fixative used. Muscles
from the Alpine brown experimental BASE cattle (#995) were
fixed in 10% formalin and embedded in paraffin. Five-mm-thick
sections were pre-treated following the protocol by Okada and co-
workers [41] and probed with the anti-PrP monoclonal antibody
F99/97.6.1 (VMRD Inc., Pullman,WA, USA, 1:5000). The
immunoreactions were visualized using an automated system
Bond immunostainer (Vision BioSystems, Melbourne, Victoria,
Australia) and a Fast Red/Alkaline phosphatase based reaction
product.
Muscles from the Holstein-Friesian natural BASE cattle
(#126752/09) were fixed in Carnoy. Five-mm-thick sections from
paraffin-embedded blocks were pre-treated with proteinase K
followed by guanidine isothiocyanate as described previously [40]
and probed with the monoclonal antibody F99/97.6.1 (1:1000).
PrP
res immunoreactivity was visualized using a biotinylated anti-
mouse antibody and the avidin-biotin peroxidase complex (Vector
Laboratories, Burlingame, CA, USA, 1:200), and 3,39-diamino-
benzidine (Dakocytomation) as chromogen; the sections were
counterstained with Meyer’s hematoxylin.
To verify the specificity of immunoreactions, the antibody F99/
97.6.1 was pre-absorbed with a synthetic peptide homologous to
residues 228–233 of bovine PrP before immunostaining. In order
to maximize the possibility to detect PrP
res deposition in muscle
fibres, three serial sections from experimental and natural BASE
cattle were collected at 25 mm intervals. The two sections adjacent
Infectivity in Skeletal Muscles of BASE Cattle
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hematoxylin-eosin and X-34, an amyloid-binding, fluorescent
derivative of Congo red [42].
Western blot analysis
Frozen mouse brain and cattle muscle samples were homoge-
nized in nine volumes of lysis buffer (100 mM sodium chloride,
10 mM EDTA, 0,5% Nonidet P-40, 0,5% sodium deoxycholate in
10 mM Tris-HCl, ph 7.4) and digested with 50 mg/ml of
proteinase K (Boehringer Mannheim) for 1 h at 37uC. Digestion
was blocked by addition of phenylmethylsulfonylfluoride. Samples
were resolved using 12,5% polyacrylammide gels and then
transferred onto PVDF membrane (Immobilon P, Millipore,
Bedford, MA). Membranes were blocked with 5% non-fat dry milk
in 10 mM Tris, 150 mM sodium chloride, 0.1% Tween-20,
ph 7.5, for 1 hour and incubated overnight at 4uC with the
monoclonal antibody 6H4 (Prionics, 1:5000). Blots were developed
using the Amersham enhanced chemiluminescence system (GE-
Healthcare Ltd., St. Giles, UK) and visualized on an autoradio-
graphic film. To enhance PrP
res detection, samples that were
negative on a standard immunoblot analysis, were subjected to
PTA precipitation as previously described [16] and analyzed by
Western blot.
Statistical analysis
Statistical analysis was performed using the GraphPad-Prism
software. Kaplan-Meier survival curves were plotted, and
differences in survival between groups of mice inoculated with
different tissues were compared using the log-rank test.
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